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Experimental evidence refuting Dale’s principle, the notion that each neuron synthesizes and releases only
one neurotransmitter, has accumulated in the past four decades, and cotransmission by multiple neurotrans-
mitters from the same axon terminal (and even from the same vesicle) now is well documented. Heretofore, in
all examples of cotransmission, each released neurotransmitter acted on a different receptor. Lu, Rubio, and
Trussell, however, demonstrate in this issue of Neuron the first instance of cotransmission in which two
neurotransmitters act on the same postsynaptic receptor.That a single neuron canmake use of mul-
tiple neurotransmitters was controversial
when first proposed (Burnstock, 1976),
but now is well accepted (Seal and
Edwards, 2006). Though this phenome-
non (called cotransmission) initially was
thought to be limited to neuromodulatory
systems (e.g., release of neuropeptides
from monoaminergic neurons; Hokfelt
et al., 2000), cotransmission involving
the ‘‘fast’’ neurotransmitters acetylcho-
line, glutamate, GABA, and glycine has
been observed at a number of central
synapses (Seal and Edwards, 2006). The
best-studied example of cotransmission
is the corelease of GABA and glycine
in the spinal cord and brainstem, docu-
mented first by Jonas et al. (1998) and
thereafter by a number of other investiga-
tors.
Thework of Jonas et al. (1998) validated
a hypothesis of GABAergic and glyciner-
gic cotransmission based on immunohis-
tochemical and biochemical studies: at
some inhibitory synapses in the brainstem
and spinal cord, GABA and glycine are
colocalized presynaptically in nerve termi-
nals, in which they are substrates for the
same vesicular transporter, and GABAARs
and GlyRs are colocalized postsynapti-
cally (Burger et al., 1991; Todd et al.,
1996). By recording individual quantal,
miniature inhibitory postsynaptic currents
(mIPSCs) mediated by both GABAARs
and GlyRs, Jonas et al. (1998) and others
confirmed that GABAA andGlyRs colocal-
ized at the same synapses are activated
by GABA and glycine released from
the same vesicle. This cotransmission byGABA and glycine likely permits the
time course of postsynaptic inhibition at
single synapses to be varied over a wide
range, as GABAAR-mediated synaptic
currents are slower than GlyR-mediated
ones (e.g., Jonas et al., 1998).
Importantly, in previously described
examples of cotransmission, each neuro-
transmitter acts on a different receptor
at the same synapse (i.e., at the same
synapse, GABA binds to GABARs and
glycine binds to GlyRs). Here, Lu, Rubio,
and Trussell (Lu et al., 2008) describe
a new and unique variant of GABAergic
and glycinergic cotransmission in which
GABA and glycine act as coagonists at
the same receptor (the GlyR). The joint
action of GABA (a weak agonist) and gly-
cine (a strong agonist) on the receptor
accelerates its rate of deactivation,
thereby accelerating the time course of
the glycinergic synaptic conductance.
This remarkable finding raises the possi-
bility that the timing of synaptic inhibition
throughout the CNS may be modulated
by the neurotransmitter composition of
individual vesicles.
Lu, Rubio, and Trussell examined glyci-
nergic synaptic inputs to the rat medial
nucleus of the trapezoid body (MNTB),
an auditory brainstem nucleus that is
part of the neural circuitry underlying
sound localization (reviewed by Kandler
and Gillespie, 2005). The MNTB receives
excitatory input from the contralateral
cochlear nucleus and sends an inhibitory
(glycinergic) projection to the ipsilateral
superior olivary complex, which receives
excitatory input from the ipsilateral co-
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sNeuron 5hlear nucleus. By integrating ipsilateral
xcitatory inputs and contralateral in-
ibitory inputs, superior olivary neurons
ncode differences in intraural stimulus
iming and intensity.
To permit small differences in intraural
timulus timing and intensity to be en-
oded, signal transfer between the audi-
ory nuclei in the brainstem must be pre-
ise and reliable. Excitatory input to each
NTBneuron consists of a single calyceal
erminal (from an axon of a neuron in the
ochlear nucleus) containing hundreds
f glutamatergic active zones; as a conse-
uence, MNTB neurons exhibit large,
ast excitatory synaptic conductances
150 ns, rise time z150 ms, half-width
500 ms) that ensure that even high-
requency input from the cochlear nucleus
s encoded in action potentials that are
ransmitted reproducibly to the superior
live (e.g., Taschenberger and von Gers-
orff, 2000). Synaptic inhibition in the ma-
ure MNTB is equally fast and powerful:
watramani et al. (2004) found that mature
NTB neurons exhibit a glycinergic con-
uctance equivalent in magnitude and
ime course to their excitatory conduc-
ance and sufficient to shunt calyceal exci-
ation and inhibit action potential genera-
ion. In fact, the observed time course of
nhibition was so rapid that the investiga-
ors were compelled to comment: ‘‘.it
eems likely that the [glycine] receptors in
ature MNTB contain a novel subunit or
osttranslational modification (Awatra-
ani et al., 2004).’’
In this manuscript, Lu, Rubio, and Trus-
ell demonstrate that the rapid timecourse7, February 28, 2008 ª2008 Elsevier Inc. 475
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Previewsof inhibition at glycinergic synapses onto
MNTB neurons arises not from unique
intrinsic properties of the postsynaptic
GlyRs but rather from their behavior
when both the weak agonist GABA and
the strong agonist glycine are bound
jointly during GABAergic and glycinergic
cotransmission. The path by which this
conclusion is reached is an interesting
one, and two observations appear to
have directed the authors toward it. One,
although developmental shifts from inhib-
itory cotransmission to pure glycinergic
inhibition have been documented in the
auditory brainstem, it is uncertain whether
these reflect a loss of presynaptic GABA,
postsynaptic GABAARs, or both (Kandler
and Gillespie, 2005). Two, the decay
of GlyR-mediated macroscopic currents
evoked by rapid application of glycine to
outside-out patches excised from MNTB
neurons is much slower than the decay
of GlyR-mediated synaptic currents re-
corded in those same neurons (Lu et al.,
2008).
Lu, Rubio, and Trussell postulated
that were GABA to be released from
mature glycinergic terminals presynaptic
to MNTB neurons, it would affect the be-
havior of postsynaptic GlyRs. Thus, the
mismatch between the observed time
courses of GlyR-mediated patch and syn-
aptic currents reflects the fact that glycine
is applied alone to elicit patch currents,
but GABA and glycine are coagonists
of GlyRs during synaptic transmission.
It was relatively straightforward for the au-
thors to demonstrate that coapplication of
GABA and glycine accelerates GlyR-me-
diated macroscopic patch currents, mak-
ing them resemble more closely mIPSCs
(Figures 1C–1E in Lu et al., 2008) and
to prove by electron microscopic immu-
nohistochemistry that GABA and glycine
are colocalized in inhibitory axon termi-
nals presynaptic to MNTB neurons (Fig-
ures 4, S2, and S3 in Lu et al., 2008).
How, though, could Lu, Rubio, and Trus-
sell prove that synaptically released
GABA and glycine act on the same GlyRs
on MNTB neurons?
One possible line of experimentation
would make use of genetically altered
mice lacking the enzyme that synthesizes
GABA from glutamate: glutamic acid de-
carboxylase (GAD; reviewed by Sogho-
monian and Martin, 1998). There are
two GAD isoforms, GAD65 and GAD67;476 Neuron 57, February 28, 2008 ª2008 ElGAD67 knockout mice die at birth;
GAD65 mice are viable, but exhibit altered
activity-dependent plasticity in sensory
(visual) cortex as well as other neurologi-
cal deficits (Hensch, 2005). Given that
postnatal development of auditory brain-
stem microcircuits is activity dependent
(Kandler and Gillespie, 2005), the GAD65
knockout mouse is not an optimal model
for the study of GABAergic and glyciner-
gic cotransmission to mature MNTB
neurons.
Fortunately, a simple pharmacological
manipulation can reduce vesicular GABA
concentration. Because GABAergic nerve
terminals possess neuronal glutamate
transporters to provide GAD with sub-
strate, pharmacological blockade of these
transporters inhibits GABAergic synaptic
transmission. Lu, Rubio, and Trussell rea-
soned that blocking glutamate uptake into
inhibitory terminals would reduce the
GABAergic component of cotransmission,
thereby reducing the effect of GABA on
GlyRs and slowing mIPSCs. They were
correct, as illustrated in Figure 6 of their ar-
ticle, and their observation was confirmed
by blocking the effects of glutamate up-
take inhibitors with a GAD inhibitor (which
also reduced the GABAergic component
of cotransmission).
In summary, Lu, Rubio, and Trussell
have demonstrated quite convincingly
that cotransmission by GABA and glycine
shortens the timecourseofGlyR-mediated
synaptic conductances in theMNTB.Why,
though, is GABA necessary to accelerate
glycinergic transmission? The answer
likely lies in the fact that relative to
GABAARs, GlyRs are limited in their kinetic
range. Dozens of distinct GABAARs, com-
posed of pentameric combinations of
multiple subunits, exist in the mammalian
nervous system, and they differ widely in
their kinetics and ability to be modulated
(Mody andPearce, 2004). GlyRs, however,
are significantly less diverse: in the mature
mammalian nervous system, most GlyRs
are thought to be heteromeric pentamers
comprising a combination of one of two a
subunits (a1 or 3, with a1 being by far the
most common) and one b subunit (Lynch,
2004). Because GlyR composition is not
a variable that canbechangedsignificantly
from synapse to synapse, cotransmission
by GABA and glycine presents a flexible
method by which the time course of
glycinergic transmission can be adjustedsevier Inc.to match the requirements of different
neural circuits.
The findings of Lu, Rubio, and Trussell
raise the possibility that GlyRs are modi-
fiedbyGABAergic cotransmissionat other
synapses in the central nervous system
in which both GABA and glycine are found
presynaptically. Apart from the auditory
brainstem, in which many inhibitory neu-
rons produce both neurotransmitters,
an interesting example of cotransmission
is found in the cerebellum: Golgi cells
contain GABA and glycine and contact
both granule cells and unipolar brush cells
(Dugue et al., 2005). Golgi-granule cell
transmission appears to be mediated
solely by GABAARs and Golgi-unipolar
brushcell transmissionbyeitherGABAARs
or GlyRs, but not both in an individual
neuron (Dugue et al., 2005). Perhaps the
GlyRs on unipolar brush cells bind GABA
as well as glycine? Further, it is interesting
to consider the possibility that glycinemay
act as a coagonist at some GABAARs.
This study by Lu, Rubio, and Trussell
also serves to answer a question that
has been in my mind for years. When I
studied the relationship between GlyR
channel kinetics and the time course
of glycinergic synaptic transmission to
hypoglossal motoneurons as a graduate
student, I could not understand why the
macroscopic GlyR patch currents that I
recorded were slower than glycinergic
mIPSCs, no matter what experimental
manipulation the patch currents were
subjected to. The irony of this is that while
I was doing my thesis work, another grad-
uate student in the laboratory, Jennifer
O’Brien, was documenting GABAergic
and glycinergic cotransmission to hypo-
glossal motoneurons! If only we had
thought to combine our projects!
Of course, a hallmark of a great scien-
tific study is the ability to approach an
established problem from a fresh per-
spective, and certainly the present work
by Lu, Rubio, and Trussell characterizes
this. Who would have thought that GABA
is an endogenous ligand for GlyRs? Not
me, unfortunately.
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While Trk receptors can be activate
GPCR ligands, its physiological sign
a novel mechanism of TrkB transact
neurotrophins and that such a trans
A dogma in the neurotrophin field, and
indeed in cell signaling in general, is that
neurotrophins signal by binding their cog-
nate Trk receptors at the cell surface.
Ligand binding initiates Trk receptor di-
merization and phosphorylation via its
intrinsic tyrosine kinase. Phosphorylated
intracellular cytoplasmic tails of Trk act
as docking sites for adaptor molecules,
which in turn activate any/all of the three
major downstream signaling pathways
(Ras/MAPK/Erk, PI3K/Akt, and PLC-g)
to regulate neuronal survival, neurite
outgrowth and branching, and synaptic
transmission and plasticity (Huang and
Reichardt, 2003). Until recently, Trk re-
ceptors were believed to be activated
solely by neurotrophins. For example,
TrkB is activated by either brain-derived
neurotrophic factor (BDNF) or neurotro-
phin 4 (NT4). A neurotrophin-independent
mechanism for TrkB activation was impli-
cated by the observation that neither
a null mutation of NT4 nor a conditional
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ificance in the brain remains unknow
ivation. They show that zinc ions ca
activation is important for mossy fib
tion during epileptogenesis (He et al.,
2006, 2004). Intriguing studies by Lee
et al. (Lee and Chao, 2001; Lee et al.,
2002) provided evidence that, at least
in cell culture, Trk signaling can occur
independently of direct ligand/neurotro-
phin binding through ‘‘transactivation’’
by G protein-coupled receptor (GPCR)
ligands such as adenosine or the neuro-
peptide PACAP. As the term suggests,
transactivation refers to ligand-indepen-
dent, indirect activation of receptor sig-
naling. Further studies demonstrated
that Trk receptors are activated intracellu-
larly through Src kinase-mediated tyro-
sine phosphorylation. However, it was un-
clear whethermolecules other thanGPCR
ligands can transactivate Trks. Moreover,
the physiological significance of Trk re-
ceptor transactivation in the brain in vivo
was also difficult to ascertain. The study
by Huang et al. published in this issue of
Neuron represents a major leap forward:
the divalent cation zinc released in the
hippocampal CA3 area in response to
Neuron 57Seal, R.P., and Edwards, R.H. (2006). Curr. Opin.
Pharmacol. 6, 114–119.
Soghomonian, J.J., andMartin, D.L. (1998). Trends
Pharmacol. Sci. 19, 500–505.
Taschenberger, H., and von Gersdorff, H. (2000).
J. Neurosci. 20, 9162–9173.
Todd, A.J., Watt, C., Spike, R.C., and Sieghart, W.
(1996). J. Neurosci. 16, 974–982.ity
Development
anner through ‘‘transactivation’’ by
n. Huang et al. have now identified
n transactivate TrkB independent of
er long-term potentiation (LTP).
neural activity not only transactivates
TrkB in vivo, but this transactivation plays
a significant role in long-term potentiation
(LTP) at the mossy fiber (MF)-CA3 synap-
ses (Huang et al., 2008).
Previous studies have suggested that
zinc (and copper) can activate TrkB
by converting proBDNF to mature BDNF
(mBDNF) through extracellular metallo-
proteinases (Hwang et al., 2005, 2007). In
the present study, Huang et al. performed
a series of experiments to show that zinc
can directly activate TrkB in the absence
of BDNF. First, zinc, but not other divalent
or monovalent cations (Mg2+, Ca2+, K+,
Na+, etc.), selectively activates TrkB (not
TrkA or TrkC) and its downstream signal-
ing pathways (Erk1/2, CREB, and PLC-g).
Second, zinc transactivates TrkB not only
in wild-type (+/+) neurons when extracel-
lular BDNF has been removed by the
scavenger TrkB-IgG, but also in neurons
derived from BDNF null mutant (/) or
in TrkB-expressing heterologous cells.
Third, zinc-induced TrkB activation was
, February 28, 2008 ª2008 Elsevier Inc. 477
